Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
The Journal of Biological Chemistry|December 16, 2006
Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish modelNiclas W Schiffer, Sarah A Broadley, Thomas Hirschberger, et al.Journal of Neurology|August 7, 2025
Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysisUnnah Leitner, Sin Hong Chew, Jessica Blanch, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2008
Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosisS A Broadley, D Vanags, B Williams, et al.Journal of Neurology|July 2, 2021
NMOSD and MS prevalence in the Indigenous populations of Australia and New ZealandWajih Bukhari, Elham Khalilidehkordi, Deborah F Mason, et al.Multiple Sclerosis and Related Disorders|November 26, 2022
Long-term dietary acid load is associated with depression in multiple sclerosis, but less evidence was found with fatigue and anxietyA Saul, B V Taylor, L Blizzard, et al.Multiple Sclerosis and Related Disorders|August 9, 2025
Diet-dependent acid-base load is not associated with rate of relapse, annualised disability change, FLAIR, and black hole lesion volume on MRI in a prospective cohort study of those with multiple sclerosisA Saul, B V Taylor, L Blizzard, et al.Scientific Reports|July 18, 2023
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort studyValery Fuh-Ngwa, Jac C Charlesworth, Yuan Zhou, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 2, 2023
Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progressionXin Lin, Yuanhao Yang, Valery Fuh-Ngwa, et al.Multiple Sclerosis and Related Disorders|January 25, 2026
The association between flavonoid intake and first clinical diagnosis of central nervous system demyelination: a case-control studyWolfgang Marx, Mojtaba Lotfaliany, Lucinda J Black, et al.Frontiers in Neurology|October 23, 2019
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSDKerri Prain, Mark Woodhall, Angela Vincent, et al.Pageof 10